Skip to main content

Advertisement

SpringerLink
Log in

Botulinum toxin in paediatric urology: a systematic literature review

  • Review Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

The use of botulinum toxin in paediatric urology has become increasingly widespread during recent years; however, the evidence base for its clinical use has been from adult urology centres and trials. The mechanism of action of this potent neurotoxin is discussed and evidence for its efficacy and safety is reviewed in both the adult and paediatric literature. Second, an electronic literature search was performed using the keywords paediatric urology, botulinum toxin, bladder, sphincter, and voiding dysfunction (excluding abstracts, letters and case reports). A total of 225 children in 10 peer-reviewed publications were evaluated with 165 paediatric patients with neurogenic overactivity (6 studies), 21 patients with idiopathic overactivity (1 study) and 39 patients with voiding dysfunction (3 studies). Specifically, we discuss the main indications of intravesical injections for detrusor overactivity and of intrasphincteric injections for refractory voiding dysfunctions in the paediatric population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schurch B (2006) Botulinum toxin for the management of bladder dysfunction. Drugs 66:1301–1318. doi:10.2165/00003495-200666100-00001

    Article  PubMed  CAS  Google Scholar 

  2. Dykstra DD, Sidi AA, Scott AB et al (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139:919–922

    PubMed  CAS  Google Scholar 

  3. Phelan MW, Franks M, Somogyi GT et al (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165:1107–1110. doi:10.1016/S0022-5347(05)66438-5

    Article  PubMed  CAS  Google Scholar 

  4. Smith CP, Radziszewski P, Borkowski A et al (2004) Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64:871–875. doi:10.1016/j.urology.2004.06.073

    Article  PubMed  Google Scholar 

  5. Zermann D, Ishigooka M, Schubert J, Schmidt RA (2000) Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 38:393–399. doi:10.1159/000020314

    Article  PubMed  CAS  Google Scholar 

  6. Chuang YC, Chancellor MB (2006) The application of botulinum toxin in the prostate. J Urol 176:2375–2382. doi:10.1016/j.juro.2006.07.127

    Article  PubMed  CAS  Google Scholar 

  7. Schurch B, Corcos J (2005) Botulinum toxin injections for paediatric incontinence. Curr Opin Urol 15:264–267. doi:10.1097/01.mou.0000172401.92761.86

    Article  PubMed  Google Scholar 

  8. de Paiva A, Meunier FA, Molgo J et al (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96:3200–3205. doi:10.1073/pnas.96.6.3200

    Article  PubMed  Google Scholar 

  9. Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644–650. doi:10.1016/j.eururo.2005.12.010

    Article  PubMed  CAS  Google Scholar 

  10. Brady CM, Apostolidis A, Harper M et al (2004) Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment. BJUI 93:770–776. doi:10.1111/j.1464-410X.2003.04722.x

    Article  CAS  Google Scholar 

  11. Apostolidis A, Popat RB, Yiangou Y et al (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibres following intra-detrusor injections of Botulinum toxin for human detrusor overactivity. J Urol 174:977–983. doi:10.1097/01.ju.0000169481.42259.54

    Article  PubMed  CAS  Google Scholar 

  12. Khera M, Somogyi GT, Kiss S et al (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45:987–993. doi:10.1016/j.neuint.2004.06.001

    Article  PubMed  CAS  Google Scholar 

  13. Wiseman OJ, Fowler CJ, Landon DN (2003) The role of the human bladder lamina propria myofibroblast. BJUI 91:89–93. doi:10.1046/j.1464-410X.2003.03802.x

    Article  CAS  Google Scholar 

  14. Lagou M, Drake MJ, Markerink-van Ittersum M et al (2006) Interstitial cells and phasic activity in the isolated mouse bladder. BJUI 98:643–650

    Article  CAS  Google Scholar 

  15. Welch MJ, Purkiss JR, Foster KA (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38:245–258. doi:10.1016/S0041-0101(99)00153-1

    Article  PubMed  CAS  Google Scholar 

  16. Cui M, Khanijou S, Rubino J, Aoki KR (2004) Subcutaneous adminstration of botulinum toxin A reduces formalin-induced pain. Pain 107:125–133. doi:10.1016/j.pain.2003.10.008

    Article  PubMed  CAS  Google Scholar 

  17. Reitz A, Denys P, Fermnanian C, Schurch B et al (2007) Do repeat intradetrusor botulinum toxin type A injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 52:1729–1735. doi:10.1016/j.eururo.2007.08.052

    Article  PubMed  Google Scholar 

  18. Schurch B, Stohrer M, Kramer G et al (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692–697. doi:10.1016/S0022-5347(05)67283-7

    Article  PubMed  CAS  Google Scholar 

  19. Reitz A, Stohrer M, Kramer G et al (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510–515. doi:10.1016/j.eururo.2003.12.004

    Article  PubMed  CAS  Google Scholar 

  20. Schurch B, de Seze M, Denys P et al (2005) Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo-controlled 6-month study. J Urol 174:196–200. doi:10.1097/01.ju.0000162035.73977.1c

    Article  PubMed  CAS  Google Scholar 

  21. Sahai A, Khan MS, Dasgupta P (2007) Efficacy of botulinum toxin-A for treating detrusor overactivity: results from a single center, randomized, double-blind, placebo-controlled trial. J Urol 177:2231–2236. doi:10.1016/j.juro.2007.01.130

    Article  PubMed  CAS  Google Scholar 

  22. Unwala DJ, Barboglio P, Gousse AE (2007) Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution? Curr Urol Rep 8:419–424. doi:10.1007/s11934-007-0041-5

    Article  PubMed  Google Scholar 

  23. Ahmed HU, Shergill IS, Arya M, Shah PJR (2006) Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol 3:368–380. doi:10.1038/ncpuro0521

    Article  PubMed  Google Scholar 

  24. Harper M, Popat RB, DasGupta R et al (2003) A minimally invasive technique for outpatient local anaesthetic adminstration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJUI 92:325–326. doi:10.1046/j.1464-410X.2003.04312.x

    Article  CAS  Google Scholar 

  25. Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol 53:275–287. doi:10.1016/j.eururo.2007.10.013

    Article  PubMed  CAS  Google Scholar 

  26. Schulte-Baukloh H, Michael T, Schobert J et al (2002) Efficacy of botulinum A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59:325–327. doi:10.1016/S0090-4295(01)01641-7

    Article  PubMed  CAS  Google Scholar 

  27. Schulte-Baukloh H, Michael T, Stürzebecher B et al (2003) Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44:139–143. doi:10.1016/S0302-2838(03)00136-2

    Article  PubMed  CAS  Google Scholar 

  28. Riccabona M, Koen M, Schindler M et al (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171:845–848. doi:10.1097/01.ju.0000108892.35041.2d

    Article  PubMed  CAS  Google Scholar 

  29. Altaweel W, Jednack R, Bilodeau C, Corcos J (2006) Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol 175:1102–1105. doi:10.1016/S0022-5347(05)00400-3

    Article  PubMed  CAS  Google Scholar 

  30. Kajbafzadeh AM, Moosavi S, Tajik P et al (2006) Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele. Urology 68:1091–1096. doi:10.1016/j.urology.2006.05.056

    Article  PubMed  Google Scholar 

  31. Akbar M, Abel R, Seyler TM et al (2007) Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJUI 100:639–645. doi:10.1111/j.1464-410X.2007.06977.x

    Article  Google Scholar 

  32. Neel KF, Soliman S, Salem M et al (2007) Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. J Urol 178:2593–2598. doi:10.1016/j.juro.2007.08.032

    Article  PubMed  CAS  Google Scholar 

  33. Kalsi V, Popat RB, Apostolidis A et al (2006) Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 49:519–527. doi:10.1016/j.eururo.2005.11.006

    Article  PubMed  CAS  Google Scholar 

  34. Hoebeke P, De Caestecker K, Vande Walle J et al (2006) The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 176:328–331. doi:10.1016/S0022-5347(06)00301-6

    Article  PubMed  CAS  Google Scholar 

  35. Hinman FJ (1986) Non-neurogenic neurogenic bladder (the Hinman syndrome)—15 years later. J Urol 136:769–772

    PubMed  Google Scholar 

  36. Mokhless I, Gaafar S, Fouda K et al (2006) Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J Urol 176:1767–1770. doi:10.1016/j.juro.2006.03.119

    Article  PubMed  CAS  Google Scholar 

  37. Radojicic ZI, Perovic SV, Milic NM (2006) Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin. J Urol 176:332–336. doi:10.1016/S0022-5347(06)00298-9

    Article  PubMed  Google Scholar 

  38. Petronijevic V, Lazovic M, Vlajkovic M et al (2007) Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding. J Urol 178:2599–2602. doi:10.1016/j.juro.2007.08.027

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Guy’s Hospital, Great Maze Pond, London, SE1 9RT, UK

    Ranan DasGupta

  2. Department of Paediatric Urology, St George’s Hospital, Tooting, London, SW17 0QT, UK

    Feilim Liam Murphy

Authors
  1. Ranan DasGupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feilim Liam Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Feilim Liam Murphy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

DasGupta, R., Murphy, F.L. Botulinum toxin in paediatric urology: a systematic literature review. Pediatr Surg Int 25, 19–23 (2009). https://doi.org/10.1007/s00383-008-2260-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-008-2260-3

Keywords

Search

Navigation